Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA5A | P35218 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | TTR | P02766 | 2/20 | 0.42 |
| ▸ | ESR1 | P03372 | 3/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | EYA3 | Q99504 | 1/20 | 0.39 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | APP | P05067 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | TPMT | P51580 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.36 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13624841 | 0.91 | CA5A (0.56) | CA5ALMNATTRESR1CYP2C19 | |
| SCHEMBL1644952 | 0.86 | CA5A (0.56) | CA5ALMNAESR1HSD17B1MEN1 | |
| SCHEMBL22991530 | 0.80 | TTR (0.44) | LMNATTRESR1CYP2C19EYA3 | |
| SCHEMBL13144722 | 0.80 | CA5A (0.50) | CA5ALMNAESR1HSD17B1MEN1 | |
| SCHEMBL16769478 | 0.79 | CA5A (0.48) | CA5ALMNAHSD17B1MEN1KMT2A | |
| SCHEMBL14277282 | 0.79 | CA5A (0.48) | CA5ALMNAESR1HSD17B1KMT2A | |
| SCHEMBL6900728 | 0.78 | CA5A (0.48) | CA5ALMNAESR1HSD17B1MEN1 | |
| SCHEMBL21854475 | 0.78 | KDM4E (0.57) | LMNAESR1MEN1KMT2ACA1 | |
| SCHEMBL6944075 | 0.78 | LMNA (0.78) | CA5ALMNACYP2C19MEN1KMT2A | |
| SCHEMBL2716447 | 0.77 | TTR (0.48) | CA5ALMNATTRESR1HSD17B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3348557-B1 | IMIDAZO[1,2A]PYRIDINES FOR TREATING OR PREVENTING HYPERURICEMIA OR GOUT | JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD (CN) | 2020-04-29 | — | — | EP | disclosed |
| US-10399971-B2 | Compound for treating or preventing hyperuricemia or gout | JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO., LTD. (CN) | 2019-09-03 | — | — | US | disclosed |
| US-10399971-B2 | Compound for treating or preventing hyperuricemia or gout | JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO., LTD. (CN) | 2019-09-03 | — | — | US | disclosed |
| US-20180282321-A1 | COMPOUND FOR TREATING OR PREVENTING HYPERURICEMIA OR GOUT | JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO., LTD. (CN) | 2018-10-04 | — | — | US | disclosed |
| EP-3348557-A1 | COMPOUND FOR TREATING OR PREVENTING HYPERURICEMIA OR GOUT | Jiangsu Atom Bioscience And Pharmaceutical Co., Ltd (CN) | 2018-07-18 | — | — | EP | disclosed |
| EP-3348557-A1 | COMPOUND FOR TREATING OR PREVENTING HYPERURICEMIA OR GOUT | Jiangsu Atom Bioscience And Pharmaceutical Co., Ltd (CN) | 2018-07-18 | — | — | EP | disclosed |
| WO-2017041732-A1 | COMPOUND FOR TREATING OR PREVENTING HYPERURICEMIA OR GOUT | 江苏新元素医药科技有限公司 | 2017-03-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180282321-A1 | COMPOUND FOR TREATING OR PREVENTING HYPERURICEMIA OR GOUT | SLC10A1, SLC5A1, SLC10A6 | CA5A 1148/4885LMNA 2942/4885TTR 1462/4885 |
| US-10399971-B2 | Compound for treating or preventing hyperuricemia or gout | SLC10A1, SLC5A1, SLC10A6 | CA5A 1148/4885LMNA 2942/4885TTR 1462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.